Clinical Trials Directory

Trials / Completed

CompletedNCT01558557

Gluten Free Diet in People With Schizophrenia: A Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
University of Maryland, Baltimore · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Background: Celiac disease is an immune-mediated reaction to gluten, presenting with diarrhea, weight loss, abdominal complaints and a range of less common associated neurologic and psychiatric symptoms. Evidence of a link between schizophrenia and celiac disease dates back to 1961. Recent evidence shows that 5.5% (age adjusted) of persons with schizophrenia participating in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study had a level of antibodies to tTG that is consistent with a diagnosis of celiac disease (compared to 1.1% of the comparison sample). An unexpected finding was that 23.4% (age adjusted) of the CATIE sample had antibodies to gliadin (compared to 2.9% of the comparison sample). It is hypothesized that a gluten free diet in people with schizophrenia who have Celiac disease or gluten sensitivity will have improvement in symptoms and quality of life. Objectives: The aim of this proposed pilot study is to establish the feasibility of a initiating and maintaining a Gluten-free diet in these two groups. For this study The investigators will identify 8 individuals who have positive assays to tTG antibodies and confirmed celiac disease (N=4), or positive assays for anti-gliadin antibodies (N=4). The investigators plan to consent at least 2 subjects from each group and ask them to participate in a two-week open label treatment of a gluten free diet. The groups are; 1. Celiac disease (positive tTG antibody); and 2. Positive assay on Antigliadin antibodies

Conditions

Interventions

TypeNameDescription
OTHERGluten Free DietParticipants will be given a Gluten Free Diet for 2 weeks

Timeline

Start date
2008-06-01
Primary completion
2014-01-01
Completion
2014-01-01
First posted
2012-03-20
Last updated
2019-09-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01558557. Inclusion in this directory is not an endorsement.